APA (7th ed.) Citation

Muravyev, Y. V., Gridina, G. I., & Karateev, D. E. (2013). Thromboembolism is an unexpected poor response resulting from the use of the tumor necrosis factor inhibitor adalimumab. IMA PRESS LLC.

Chicago Style (17th ed.) Citation

Muravyev, Yuri Vladimirovich, G I. Gridina, and D E. Karateev. Thromboembolism Is an Unexpected Poor Response Resulting from the Use of the Tumor Necrosis Factor Inhibitor Adalimumab. IMA PRESS LLC, 2013.

MLA (9th ed.) Citation

Muravyev, Yuri Vladimirovich, et al. Thromboembolism Is an Unexpected Poor Response Resulting from the Use of the Tumor Necrosis Factor Inhibitor Adalimumab. IMA PRESS LLC, 2013.